Inhibition of the glycogen synthase kinase 3 (GSK3) by the small molecule 6-bromoindirubin 3’-oxime (BIO), prevented mice from lethal GVHD in a xenogeneic model by STAT1/3 suppression and subsequent decrease of Th1 effector cytokines (187). This evidence concerns the gene STAT1 and graft versus host disease.